Fig. 6.

Distribution of immunotherapy response markers in high- and low-risk groups. (a), (b), (c), and (d), the distribution of TMB, number of neoantigens, number of clonal neoantigens, and number of subclonal neoantigens in high- and low-risk groups. (e), the distribution of protein level of PD-L1 in high- and low-risk groups. (f), (g), and (h) The distribution of TIDE score, T cell dysfunction score, and T cell exclusion score in high- and low-risk groups. * and **** represent P < 0.05 and P < 0.0001, respectively.